NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.2 Drugs affecting the immune response > 8.2.3 Anti-lymphocyte monoclonal antibodies > Ofatumumab with chemotherapy for treating chronic lymphocytic leukaemia (terminated appraisal) - NICE TAG TA470

Ofatumumab with chemotherapy for treating chronic lymphocytic leukaemia (terminated appraisal) - NICE TAG TA470

NICE is unable to make a recommendation about the use in the NHS of ofatumumab with chemotherapy for treating chronic lymphocytic leukaemia because no evidence submission was received from Novartis Pharmaceuticals UK. The company has confirmed that it does not intend to make a submission.

https://www.nice.org.uk/guidance/ta470

Site by Devopa
© Copyright 2019 NHS. All rights reserved.